home / stock / immpf / immpf short
Short Information | Immupharma PLC (OTCMKTS:IMMPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 103,043 |
Total Actual Volume | 341,743 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 14 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 5,152 |
Average Short Percentage | 71.03% |
Is there a IMMPF Short Squeeze or Breakout about to happen?
See the IMMPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-14-2020 | $0.19 | $0.19 | $0.19 | $0.19 | 685 | 685 | 100% |
12-10-2020 | $0.2 | $0.2 | $0.2 | $0.2 | 400 | 400 | 100% |
05-15-2020 | $0.22 | $0.22 | $0.22 | $0.22 | 10,000 | 10,100 | 101% |
02-20-2019 | $0.195 | $0.195 | $0.195 | $0.195 | 10,000 | 10,000 | 100% |
11-16-2018 | $0.27 | $0.27 | $0.27 | $0.27 | 880 | 880 | 100% |
10-25-2018 | $0.18 | $0.13 | $0.18 | $0.13 | 850 | 100 | 11.76% |
05-04-2018 | $N/A | $0.39 | $N/A | $N/A | 75 | 75 | 100% |
04-23-2018 | $0.63 | $0.54 | $0.63 | $0.54 | 29,500 | 1,500 | 5.08% |
04-20-2018 | $0.70 | $0.70 | $0.70 | $0.70 | 8,500 | 8,500 | 100% |
04-18-2018 | $0.53 | $0.495 | $0.53 | $0.495 | 15,610 | 15,610 | 100% |
04-17-2018 | $0.54 | $0.54 | $0.54 | $0.47 | 216,050 | 6,000 | 2.78% |
04-16-2018 | $2.11 | $2.11 | $2.11 | $2.11 | 3,028 | 3,028 | 100% |
04-13-2018 | $2.21 | $2.21 | $2.21 | $2.21 | 5,290 | 5,290 | 100% |
04-10-2018 | $2.43 | $2.43 | $2.43 | $2.43 | 1,000 | 1,000 | 100% |
04-09-2018 | $2.40 | $2.40 | $2.40 | $2.40 | 27,000 | 27,000 | 100% |
04-06-2018 | $2.50 | $2.50 | $2.50 | $2.50 | 3,655 | 3,655 | 100% |
04-05-2018 | $2.40 | $2.44 | $2.44 | $2.40 | 9,220 | 9,220 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Immupharma PLC Company Name:
IMMPF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ImmuPharma PLC (AIM:IMM) chief executive Tim McCarthy provides an extensive update during an interview with Proactive's Stephen Gunnion, focusing on the financial, business, and portfolio developments of the company. McCarthy clarified that the company is in a strong fina...
(NewsDirect) ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy visited Thomas Warner at the Proactive London studio after confirming to the market that the specialty biopharmaceutical will be moving forward into a key phase 2/3 adaptive clinical trial, alongside its US part...
(NewsDirect) Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com Copyright (c) 2023 TheNewswire - All rights reserved.